David Peltier

Portfolio Manager

David Peltier joined TheStreet.com as a research associate in August 2001, and writes TheStreet.com Stocks Under $10. Before that, Peltier was an analyst for Individual Investor magazine and the publication's Web site. His market interests include small-caps, technology and retail stocks. He has appeared on NPR, CNNfn and WNYW-TV.

Peltier received his bachelor's degree cum laude in finance and international business from New York University. He is also a candidate for Level II of the CFA program.

David Peltier
By This Author:
« Back
Page 1 of 164
Alert

Stocks Under $10 Weekly Summary (Stocks Under $10 $)

By David Peltier

We focused on researching new names for the model portfolio this week and used Friday's pullback to add shares to one holding.

02:17PM 11/27/09

Alert

Putting Cash to Work (Stocks Under $10 $)

By David Peltier

Today's sharp market pullback offers a good opportunity to add shares to this well positioned model portfolio name.

10:32AM 11/27/09

Article

Should You Buy It? Ferro (RealMoney.com $)

By David Peltier

The chemicals maker's recent moves could make it attractive for patient investors.

09:00AM 11/26/09

Alert

A Pair of Updates (Stocks Under $10 $)

By David Peltier

Two model portfolio names are in the news today amid chatter on an obesity-drug study and a takeout rumor.

12:28PM 11/23/09

Alert

Stocks Under $10 Weekly Summary (Stocks Under $10 $)

By David Peltier

We put some cash to work this week as the model portfolio's benchmark, the Russell 2000, fell for four straight days.

04:54PM 11/20/09

Alert

Buying on Weakness (Stocks Under $10 $)

By David Peltier

Adding to our position and upgrading our rating as we believe the company will rebound in the current period.

10:58AM 11/20/09

Alert

Poised for a Purchase (Stocks Under $10 $)

By David Peltier

This pharmaceutical name is trading lower on the session, but we will continue to monitor the price action before taking action.

11:59AM 11/19/09

Alert

Names on Our Radar (Stocks Under $10 $)

By David Peltier

Here's an update on some of the companies we've been researching since the end of earnings season.

11:14AM 11/19/09

Article

Should You Buy It? Alkermes (RealMoney.com $)

By David Peltier

Can positive trial data drive the stock higher despite new competition for a key product?

09:30AM 11/19/09

Alert

A Robust Update (Stocks Under $10 $)

By David Peltier

Shares of this recent model portfolio addition are surging on strong trial results for its erectile dysfunction drug.

09:18AM 11/18/09

« Back
Page 1 of 164
Dow Jones S&P 500 NASDAQ 10-Year Note
10,309.92 1,091.49 2,138.44 32.31
Oil *
77.12
DOWN
154.48
DOWN
19.14
DOWN
37.61
DOWN
0.48
10 Yr
3.23%
SPDR Gold
115.06
-1.48%
-1.72%
-1.73%
-1.46%
Data delayed 20 minutes

Brokerage Partners